Cargando…

Antiplatelet therapy around CABG: the latest evidence

PURPOSE OF REVIEW: The optimal antiplatelet strategy in patients after coronary artery bypass graft (CABG) surgery is unclear. We review the evidence on the efficacy and safety of DAPT after CABG and discuss potential novel antiplatelet strategies that reduce the risk of bleeding without loss of eff...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sandner, Sigrid, Redfors, Björn, Gaudino, Mario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	CORONARY ARTERY SURGERY: Edited by Marc Ruel
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552805/ https://www.ncbi.nlm.nih.gov/pubmed/37751394 http://dx.doi.org/10.1097/HCO.0000000000001078

Ejemplares similares

International patterns of dual antiplatelet therapy duration after acute coronary syndromes
por: Bueno, Héctor, et al.
Publicado: (2017)

Patient perspectives of nuisance bleeding and adherence to dual antiplatelet therapy: a qualitative study
por: Pithara, Christalla, et al.
Publicado: (2020)

Antiplatelet therapy and long-term mortality in patients with myocardial injury after non-cardiac surgery
por: Kim, Jihoon, et al.
Publicado: (2023)

Ticagrelor monotherapy after CABG—Probably not at all and definitely not forever
por: Sandner, Sigrid, et al.
Publicado: (2022)

Prognostic significance of BMI after PCI treatment in ST-elevation myocardial infarction: a cohort study from the Swedish Coronary Angiography and Angioplasty Registry
por: Jamaly, Shabbar, et al.
Publicado: (2021)

Outcomes following PCI in CABG candidates during the COVID‐19 pandemic: The prospective multicentre UK‐ReVasc registry
por: Kite, Thomas A., et al.
Publicado: (2021)

Invasive versus medically managed acute coronary syndromes with prior bypass (CABG-ACS): insights into the registry versus randomised trial populations
por: Lee, Matthew M Y, et al.
Publicado: (2021)

Commentary: Ticagrelor monotherapy—Not for CABG?
por: Sandner, Sigrid, et al.
Publicado: (2022)

Duration of dual antiplatelet therapy and stability of coronary heart disease: a 60 000-patient meta-analysis of randomised controlled trials
por: Bularga, Anda, et al.
Publicado: (2021)

Systematic review and meta-analysis of optimal P2Y(12) blockade in dual antiplatelet therapy for patients with diabetes with acute coronary syndrome
por: Rossington, Jennifer A, et al.
Publicado: (2016)

Impact of proton pump inhibitors on efficacy of antiplatelet strategies with ticagrelor or aspirin after percutaneous coronary intervention: Insights from the GLOBAL LEADERS trial
por: Ono, Masafumi, et al.
Publicado: (2022)

Cutting-Edge Coronary Imaging Guiding CABG
por: Shahinian, Jasmin H., et al.
Publicado: (2021)

Hypertension: empirical evidence and implications in 2014
por: Makridakis, Spyros, et al.
Publicado: (2014)

Clinical outcome of patients with ST‐elevation myocardial infarction and angiographic evidence of coronary artery ectasia
por: Baldi, Cesare, et al.
Publicado: (2021)

Associations of health-related quality of life with major adverse cardiovascular and cerebrovascular events for individuals with ischaemic heart disease: systematic review, meta-analysis and evidence mapping
por: Soloveva, Anzhela, et al.
Publicado: (2023)

Is It Really Safe to Discontinue Antiplatelet Therapy 12 Months After Percutaneous Coronary Intervention in Patients with Atrial Fibrillation?
por: Abdulrahman, Balen, et al.
Publicado: (2023)

Two decades after coronary radiation therapy: A single center longitudinal clinical study
por: Radhoe, Sumant P., et al.
Publicado: (2019)

Time trends in adherence to guideline recommendations for anticoagulation therapy in patients with atrial fibrillation and myocardial infarction
por: Jortveit, Jarle, et al.
Publicado: (2022)

Patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris randomised to an invasive versus conservative strategy: angiographic and procedural results from the After Eighty study
por: Tegn, Nicolai, et al.
Publicado: (2020)

Final five‐year results of the REMEDEE Registry: Real‐world experience with the dual‐therapy COMBO stent
por: Kerkmeijer, Laura S.M., et al.
Publicado: (2020)

Type 2 myocardial infarction and myocardial injury: eligibility for novel medical therapy to derisk clinical trials
por: Sykes, Robert, et al.
Publicado: (2021)

One‐year outcomes of supersaturated oxygen therapy in acute anterior myocardial infarction: The IC‐HOT study
por: Chen, Shmuel, et al.
Publicado: (2020)

Six-minute walk distance after coronary artery bypass grafting compared with medical therapy in ischaemic cardiomyopathy
por: Stewart, Ralph A H, et al.
Publicado: (2018)

Tocilizumab increases citrullinated histone 3 in non-ST segment elevation myocardial infarction
por: Helseth, Ragnhild, et al.
Publicado: (2021)

Percutaneous coronary intervention versus medical therapy in patients with angina and grey-zone fractional flow reserve values: a randomised clinical trial
por: Hennigan, Barry, et al.
Publicado: (2020)

Impact of diabetes on clinical outcomes after revascularization with the dual therapy CD34 antibody‐covered sirolimus‐eluting Combo stent and the sirolimus‐eluting Orsiro stent
por: Jakobsen, Lars, et al.
Publicado: (2022)

Impact of acute coronary syndrome on clinical outcomes after revascularization with the dual‐therapy CD34 antibody‐covered sirolimus‐eluting Combo stent and the sirolimus‐eluting Orsiro stent
por: Jakobsen, Lars, et al.
Publicado: (2022)

Is the folk medicine known as “The Secret” efficient in reducing bleeding after percutaneous coronary procedures?: a double-blinded, randomised trial
por: Ferry, Charlie, et al.
Publicado: (2022)

Intensified lipid-lowering treatment with alirocumab in patients with coronary heart disease
por: Steffens, Daniel, et al.
Publicado: (2021)

Patient delay and benefit of timely reperfusion in ST-segment elevation myocardial infarction
por: Scholz, Karl Heinrich, et al.
Publicado: (2021)

Five‐year angiographic, OCT and clinical outcomes of a randomized comparison of everolimus and biolimus‐eluting coronary stents with everolimus‐eluting bioresorbable vascular scaffolds
por: Schukraft, Sara, et al.
Publicado: (2021)

Bedside intra‐aortic balloon pump insertion in cardiac intensive care unit: A single‐center experience
por: Baldetti, Luca, et al.
Publicado: (2022)

SCAI stage reclassification at 24 h predicts outcome of cardiogenic shock: Insights from the Altshock‐2 registry
por: Morici, Nuccia, et al.
Publicado: (2022)

Angiographic control versus ischaemia-driven management of patients undergoing percutaneous revascularisation of the unprotected left main coronary artery with second-generation drug-eluting stents: rationale and design of the PULSE trial
por: De Filippo, Ovidio, et al.
Publicado: (2020)

Antiplatelet therapy with CABG: chaos in the Netherlands
por: Verheugt, F. W. A.
Publicado: (2017)

Using historical cardiac troponins to identify patients at a high risk of myocardial infarction
por: Roos, Andreas, et al.
Publicado: (2023)

Comparison of various calcium antagonist on vasospastic angina: a systematic review
por: Singh, Jaspal, et al.
Publicado: (2023)

Localising culprit artery in inferior STEMI
por: Farhat-Sabet, Ardalon, et al.
Publicado: (2023)

Diagnostic performance of a device for acoustic heart sound analysis in patients with suspected myocardial infarction
por: Lehmacher, Jonas, et al.
Publicado: (2023)

Contemporary percutaneous management of coronary calcification: current status and future directions
por: Hennessey, Breda, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_uvtjg9p0dajf67if19nf1htotm